Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000Fax+1 608-263-9830
Education & Training
University of WashingtonFellowship, Hematopathology, 2011 - 2012
University of Wisconsin Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 2007 - 2011
Beijing Medical UniversityClass of 1995
Certifications & Licensure
WA State Medical License 2011 - 2025
WI State Medical License 2008 - 2011- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 134 citationsMultipotency of purified, transplanted globose basal cells in olfactory epithelium.Xueyan Chen, Hengsheng Fang, James E. Schwob
The Journal of Comparative Neurology. 2004-02-16 - 35 citationsLabel-retaining, quiescent globose basal cells are found in the olfactory epithelium.Woochan Jang, Xueyan Chen, Daniel W. Flis, Margaret T. Harris, James E. Schwob
The Journal of Comparative Neurology. 2014-03-01 - 22 citationsNew insights into the evolution of wheat avenin-like proteins in wild emmer wheat (Triticum dicoccoides).Yujuan Zhang, Xin Hu, Shahidul Islam, Maoyun She, Yanchun Peng
Proceedings of the National Academy of Sciences of the United States of America. 2018-12-26
Abstracts/Posters
- Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/LymphomaXueyan Chen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Myelodysplastic Syndrome with Excess Blasts and Secondary Acute Myeloid Leukemia: Same Disease with Different Blast Count61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Factors Impacting Progression-Free Survival after CD19-Specific CAR-T Cell Therapy for Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Efficacy and Toxicity of JCAR014 in Combination with Durvalumab for the Treatment of Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
A 36-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial of Sodium Oligomannate for Mild-to-Moderate Alzheimer’s DementiaMarch 17th, 2021
Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort StudyMarch 15th, 2016
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
